Jinhe Biotechnology Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Jinhe Biotechnology Co.,Ltd.

34 YRS

Inner Mongolia, China

CNY 780.4 Million

246420 m²

Over 1000 people

Main Products: Chlortetracycline

Inner Mongolia, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

CRO

Total Employees

1000+ People

Plant Size

370 Acres

Production Experience

34+ Years

Registered Capital

CNY 780.4 Million

MAIN
PRODUCTS

Chlortetracycline Feed Grade (10%, in powder or granule form)

1/3

Chlortetracycline Feed Grade (10%, in powder or granule form)

CAS: 57-62-5

Packing: 25 KG/Carton; 25 KG/Woven Bag

Lead Time: In Stock

Inquiry

Chlortetracycline Feed Grade (15%, in powder or granule form)

1/3

Chlortetracycline Feed Grade (15%, in powder or granule form)

CAS: 57-62-5

Packing: 25 KG/Woven Bag; 1 KG/Woven Bag

Lead Time: In Stock

Inquiry

Chlortetracycline Feed Grade (20%, in powder or granule form)

1/3

Chlortetracycline Feed Grade (20%, in powder or granule form)

CAS: 57-62-5

Packing: 25 KG/Woven Bag; 1 KG/Woven Bag

Lead Time: In Stock

Inquiry

ABOUT US

Jinhe Biotechnology Co.,Ltd.

Jinhe Biotechnology Co, Ltd. is a publicly listed company specialized in producing veterinary 1 me dicines. After almost 30 years' development, it is today a world leader in various specifications and kinds of Chlortetracycline with an annual yield of 55000 tons and the products as Chlortetracycline Hydrochloride also rank in front of the industry. There are advanced fermentation and test equipments in the production area and all the manufacturing process is automatically controlled by computer system. Now the company has a fermention capacity of 5800m3 which ranks in front in today' s world. The company passed the US FDA inspection for the first time in 1994 VMF 5468) and re-inspections in 1997, 2000, 2007, 2010, 2014 and 2016 respectively. It also got China GMP， Europe COS and Japan FMA. Jinhe went public in July, 2012 (Stock code: 002688). In 2014, its wholly owned subsidiary Pharmgate LLC acquired Pennfield oil Company in USA, making it smoothly penetrating market of animal health in USA. More than 60% of our products are exported to USA, South-east Asia, Latin America and Europe etc., Zoetis (Pfizer) USA is our largest partner. We promise to provide our CuS- tomers with high quality products, stable supply, quick response and good after-sales service. Warmly welcome friends worldwide to negotiate with us for our mutual benefits.